Literature DB >> 2956402

Chronic herpetic infection in an immunocompromised patient: report of a case.

F Vinckier, M Boogaerts, D De Clerck, E De Clercq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2956402     DOI： 10.1016/0278-2391(87)90320-x

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  13 in total

Review 1.  Resistance of herpesviruses to antiviral drugs.

Authors:  P A Chatis; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

Review 2.  Current recommendations for the treatment of genital herpes.

Authors:  D T Leung; S L Sacks
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.

Authors:  E De Clercq; A Holý; I Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

5.  Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds.

Authors:  G Andrei; R Snoeck; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

6.  Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.

Authors:  E De Clercq; A Holý
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

7.  Antiviral drug sensitivity in ocular herpes simplex virus infection.

Authors:  M J Menage; E de Clercq; A van Lierde; V S Easty; J M Darville; S D Cook; D L Easty
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

8.  SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.

Authors:  M Witvrouw; J Balzarini; C Pannecouque; S Jhaumeer-Laulloo; J A Esté; D Schols; P Cherepanov; J C Schmit; Z Debyser; A M Vandamme; J Desmyter; S R Ramadas; E de Clercq
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

9.  In vivo antiherpesvirus activity of N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine.

Authors:  J Neyts; G Jähne; G Andrei; R Snoeck; I Winkler; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Comparative activity of various compounds against clinical strains of herpes simplex virus.

Authors:  G Andrei; R Snoeck; P Goubau; J Desmyter; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.